Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
RESEARCH TOOLSreports
Holding SNSE?
Track your performance easily
SNSE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.38 - $1.94
Previous Close$0.52
Volume431.42K
Average Volume (3M)386.69K
Market Cap
$13.11M
Enterprise Value-$29.43M
Total Cash (Recent Filing)$47.00M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Mar 06, 2025EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.19
Shares Outstanding25,151,379
10 Day Avg. Volume486,418
30 Day Avg. Volume386,692
Standard Deviation0.16
R-Squared0.00030
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.27
Price to Sales (P/S)32.62
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-79.53
Enterprise Value/Gross Profit-88.90
Enterprise Value/Ebitda1.93
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sensei Biotherapeutics News
PremiumCompany Announcements
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves
PremiumCompany Announcements
Sensei Biotherapeutics Appoints New Financial Chief
PremiumCompany Announcements
Dr. Jessie English Resigns from Sensei Biotherapeutics Board
PremiumCompany Announcements
Sensei Biotherapeutics Unveils Updated Corporate PresentationOwnership Overview
31.63% Insiders
3.28% Mutual Funds
2.82% Other Institutional Investors
59.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SNSE FAQ
What was Sensei Biotherapeutics’s price range in the past 12 months?
Sensei Biotherapeutics lowest stock price was $0.38 and its highest was $1.94 in the past 12 months.
What is Sensei Biotherapeutics’s market cap?
Currently, no data Available
When is Sensei Biotherapeutics’s upcoming earnings report date?
Sensei Biotherapeutics’s upcoming earnings report date is Mar 06, 2025 which is in 99 days.
How were Sensei Biotherapeutics’s earnings last quarter?
Sensei Biotherapeutics released its earnings results on Nov 14, 2024. The company reported -$0.29 earnings per share for the quarter, beating the consensus estimate of -$0.312 by $0.022.
Is Sensei Biotherapeutics overvalued?
According to Wall Street analysts Sensei Biotherapeutics’s price is currently Overvalued.
Does Sensei Biotherapeutics pay dividends?
Sensei Biotherapeutics does not currently pay dividends.
What is Sensei Biotherapeutics’s EPS estimate?
Sensei Biotherapeutics’s EPS estimate is -$0.28.
How many shares outstanding does Sensei Biotherapeutics have?
Sensei Biotherapeutics has 25,151,379 shares outstanding.
What happened to Sensei Biotherapeutics’s price movement after its last earnings report?
Sensei Biotherapeutics reported an EPS of -$0.29 in its last earnings report, beating expectations of -$0.312. Following the earnings report the stock price went down -13.208%.
Which hedge fund is a major shareholder of Sensei Biotherapeutics?
Among the largest hedge funds holding Sensei Biotherapeutics’s share is Duquesne Family Office LLC. It holds Sensei Biotherapeutics’s shares valued at N/A.
---
Sensei Biotherapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.57%
12-Months-Change
Fundamentals
Return on Equity
-51.04%
Trailing 12-Months
Asset Growth
-34.78%
Trailing 12-Months
Company Description
Sensei Biotherapeutics
Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The companies ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response.
---
SNSE Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SNSE
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-34.82%
initiated a buy rating 6 months ago
Copying Samantha Semenkow's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.82% per trade.
---